N9407
Neuropeptide Y Fragment 3-36 human, rat
≥95% (HPLC)
Sinónimos:
NPY 3-36
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula empírica (notación de Hill):
C175H269N53O54S
Número de CAS:
Peso molecular:
4011.40
MDL number:
UNSPSC Code:
51111800
NACRES:
NA.32
Productos recomendados
![[Pro34]-Peptide YY ≥95%](/deepweb/assets/sigmaaldrich/product/images/279/042/6c079852-dc80-45a9-988b-aeb6c84641be/640/6c079852-dc80-45a9-988b-aeb6c84641be.jpg)
Amino Acid Sequence
Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
General description
Neuropeptide Y (NPY) is a regulatory protein consisting of 36 amino acids. It is ubiquitously expressed in the heart and brain. NPY is a member of pancreatic polypeptide family. The gene encoding this protein is localized on human chromosome 7p15.
Biochem/physiol Actions
Endogenous neuropeptide that selectively binds to Y<SUB>2</SUB> and Y<SUB>5</SUB> receptors.
Neuropeptide Y (NPY) plays a vital role in various processes like feeding behavior, anxiety, epilepsy, circadian rhythm, sleep, pain and drug addiction. It also modulates appetite, body weight and obesity. The protein has potent vasoactive effects on the cardiovascular system and controls central endocrine secretion. NPY is involved in the pathogenesis of atherosclerosis and coronary artery disease.
Neuropeptide Y (NPY) plays a vital role in various processes like feeding behavior, anxiety, epilepsy, circadian rhythm, sleep, pain and drug addiction. It also modulates appetite, body weight and obesity. The protein has potent vasoactive effects on the cardiovascular system and controls central endocrine secretion. NPY is involved in the pathogenesis of atherosclerosis and coronary artery disease.
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Eitezaz Mahmood et al.
European journal of pharmacology, 882, 173261-173261 (2020-06-14)
Neuropeptide-Y (NPY) leads to angiogenesis and remodeling of the ischemic myocardium. The objective of this study is to assess the therapeutic potential of NPY in a model of acute myocardial ischemia using a nanoparticles delivery system targeted to tissue with
R Mentlein et al.
Regulatory peptides, 49(2), 133-144 (1993-12-10)
Neuropeptide Y, peptide YY and pancreatic polypeptide share an evolutionary conserved proline-rich N-terminal sequence, a structure generally known to be inert to the attack of common proteinases, but a potential target for specialized proline-specific aminopeptidases. Purified human dipeptidyl peptidase IV
K N Browning et al.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 12(1), 33-41 (2000-01-29)
Intracellular recordings were made from myenteric neurones of the guinea-pig descending colon. Neuropeptide Y (NPY) and related pancreatic polypeptides were applied by superfusion and the effects upon the amplitude of fast excitatory synaptic potentials (ESPs) and the ratio of paired
Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity
C Roche
Diabetologia, 40, 671?675-671?675 (1997)
D Grandt et al.
Regulatory peptides, 67(1), 33-37 (1996-11-14)
Neuropeptide Y (NPY 1-36) binds to Y1 and Y2 receptors with similar affinity. No endogenous molecular form of NPY with selectivity for Y1 or Y2 receptors has been described so far. We report the presence of an endogenous fragment of
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico